Article Details
Retrieved on: 2024-02-22 13:14:51
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
OncoC4 Announces First Patient with Advanced Prostate Cancer Dosed in Phase 1/2 Trial of BioNTech-partnered BNT316/ONC-392 Program. February 22 ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here